Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Oste...(. Osteoarthritis Cartilage. 2006; 1...),Health

2006; 14:154-162.

3 Schiavinato A, Finesso M, Cortivo R, & Abatangelo G (2002). Comparison

of the effects of intra-articular injections of Hyaluronan and its

chemically cross-linked derivative (Hylan G-F20) in normal rabbit knee

joints. Clin Exp Rheumatol 20, 445-454.

4 Goomer RS, Leslie K, Maris T, & Amiel D (2005). Native hyaluronan

produces less hypersensitivity than cross-linked hyaluronan. Clin Orthop

Relat Res 239-245.

5 Leopold SS, Warme WJ, Pettis PD, & Shott S (2002). Increased frequency

of acute local reaction to intra-articular hylan GF-20 (synvisc) in

patients receiving more than one course of treatment. J Bone Joint Surg

Am 84-A, 1619-1623.

6 Puttick MP, Wade JP, Chalmers A, Connell DG, & Rangno KK (1995). Acute

local reactions after intraarticular hylan for osteoarthritis of the

knee. J Rheumatol 22, 1311-1314.

7 Pullman-Mooar S, Mooar P, Sieck M, Clayburne G, & Schumacher HR (2002).

Are there distinctive inflammatory flares after hylan g-f 20

intraarticular injections? J Rheumatol 29, 2611-2614.

8 Chen AL, Desai P, Adler EM, & Di Cesare PE (2002). Granulomatous

inflammation after Hylan G-F 20 viscosupplementation of the knee : a

report of six cases. J Bone Joint Surg Am 84-A, 1142-1147.